Quantcast

SHAPE Advisor, Dr. Valentin Fuster, Named Editor of The Journal Of The American College Of Cardiology

August 21, 2013

SHAPE applauds the American College of Cardiology's decision to appoint Dr. Fuster to be the next editor-in-chief of the JACC, its acclaimed peer-reviewed publication.

Houston, TX (PRWEB) August 21, 2013

The Society for Heart Attack Prevention and Eradication (SHAPE) is pleased to congratulate Dr. Valentin Fuster, renowned cardiologist and scientific investigator, on being named the next editor-in-chief of the Journal of the American College of Cardiology (JACC). He will succeed the current editor, Anthony DeMaria, M.D., beginning in 2014.

With an interest in preventive cardiology and early identification of the vulnerable patient, Dr. Fuster has been SHAPE's distinguished scientific advisor since its founding and is a staunch supporter of SHAPE's call for improving CVD risk assessment and early detection of high risk (vulnerable) patients. He has also been a featured presenter at many of the organization's scientific symposia.

Click here to view one of Dr. Fuster's outstanding presentations at SHAPE Symposium: http://www.vcasmo.com/video/mcj1628/7856.

Dr. Morteza Naghavi, SHAPE's founder said, "Dr. Fuster has been a tireless leader in cardiovascular medicine and cutting-edge treatments for patients with coronary heart disease for many years. Thus, to those of us in the field, this recognition is neither surprising nor premature. What is also worthy of recognition is his focus on primary prevention of cardiovascular diseases by developing initiatives aimed at educating children and teenagers to adopt a heart-healthy lifestyle such as the Dr. Rooster initiative http://www.fundacionshe.com/blog/sesame-street-super-healthy-monsters-arrives-this-summer-on-our-screens/. While these population-based primary prevention programs are not usually considered cutting-edge medical newsmakers, they often save many more lives than the 'ground-breaking' trials that have more limited potential to improve the rates of morbidity and mortality of cardiovascular diseases."

Dr. Fuster, M.D, Ph.D. serves as Director of Mount Sinai Heart at the Mount Sinai Medical Center; the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health. He is the Richard Gorlin, MD/Heart Research Foundation and is Professor, Cardiology at the Mount Sinai School of Medicine in New York City.

He is also the Past President of the American Heart Association and the World Heart Federation; past member of the National Heart, Lung and Blood Institute's Advisory Council; a member of the Institute of Medicine's Board on Global Health and the General Director of the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid, Spain.

Dr. Fuster brings unmatched prestige and expertise to JACC's editor-in-chief responsibilities. SHAPE's scientific advisory board and staff offer him sincere congratulations and wish him every success.

ABOUT SHAPE

The Society for Heart Attack Prevention & Eradication (SHAPE) is a nonprofit public health organization created to promote public awareness, professional education and research related to early detection, prevention and treatment of atherosclerosis (arterial plaque), the most prevalent underlying cause of heart attacks and stroke. Identifying and treating coronary risk factors such as smoking, diabetes, obesity, high blood pressure and high cholesterol are simply not enough. SHAPE is committed to educating doctors and their patients about the devastating consequences of not screening for the accumulation of arterial plaque. Additional information is available at: http://www.shapesociety.org. To get involved with SHAPE and become a volunteer, please email us at: info(at)shapesociety(dot)org or call 713-529-4484.

http://www.shapesociety.org/professionals    

ABOUT THE SHAPE TASK FORCE

The SHAPE Task Force, an international group of leading cardiovascular physicians and researchers, has created the SHAPE Guidelines, which educates physicians how to identify asymptomatic atherosclerosis (hidden plaque) and implement proper treatment to prevent a future heart attack. According to the SHAPE Guidelines, individuals with high risk atherosclerosis (high plaque score) should be treated even if their cholesterol level is within the so called “normal range”. Knowing one's plaque score is important. In fact, it can be a matter of life and death! Additional information is available by calling 1-877-SHAPE11. Additional information is available at http://www.shapesociety.org.

The SHAPE Task Force includes the following:

Morteza Naghavi, M.D. – Executive Chairman

PK Shah, M.D. – Chair of Scientific Board

Erling Falk, M.D., Ph.D. – Chief of Editorial Committee

SHAPE Task Force Members:

Arthur Agatston, M.D., Dan Arking, Ph.D., Juan J. Badimon, Ph.D., Raymond Bahr, M.D., Daniel S. Berman, M.D., Roger S. Blumenthal, M.D., Matthew J. Budoff, M.D., Jay N. Cohn, M.D., Michael H. Davidson, M.D., George A. Diamond, M.D., James Ehrlich, M.D., Raimund Erbel, M.D., Erling Falk, M.D., Ph.D., Zahi Fayad, Ph.D., Sergio Fazio, MD, PhD, Steven B. Feinstein, M.D., Craig Hartley, Ph.D., Harvey S. Hecht, M.D., Howard Hodis, M.D., Ioannis Kakadiaris, Ph.D., Sanjay Kaul, M.D., M.P.H., Asher Kimchi. M.D., Wolfgang Koenig, M.D., Ph.D., Iftikhar J. Kullo, M.D., Daniel Lane, M.D., Ph.D., Roxana Mehran, M.D., Ralph Metcalfe, Ph.D., Morteza Naghavi, M.D., Tasneem Z. Naqvi, M.D., Jagat Narula, M.D., Paolo Raggi, M.D., George P. Rodgers, M.D., James HF Rudd, Ph.D., John Rumberger, M.D., Ph.D., Robert S. Schwartz, M.D., PK Shah, M.D., Leslee Shaw, M.D., Henrik Sillesen, M.D., Ph.D., David Spence, M.D., H. Robert Superko, M.D., Allen Taylor, M.D., Pierre-Jean Touboul, M.D.

Distinguished SHAPE Task Force Advisor: Valentin Fuster, M.D., Ph.D.

Chair of SHAPE Board of Directors: JoAnne Zawitoski

SHAPE Task Force Executive Coordinator and SHAPE CEO: Richard Hellner

Executive Director of SHAPE Center of Excellence: Jeff Fine, Ph.D.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/8/prweb11039113.htm


Source: prweb



comments powered by Disqus